TABLE 2.
CTRL | NAFL | NASH | |
TG | |||
SFA | 40.3 ± 0.66 | 41.4 ± 1.11 | 43.1 ± 0.50a |
MUFA | 48.8 ± 0.57 | 48.3 ± 0.48 | 47.7 ± 0.42 |
DUFA | 10.7 ± 0.62 | 10.2 ± 0.74 | 9.1 ± 0.37 |
PUFA | 0.20 ± 0.02 | 0.16 ± 0.02 | 0.14 ± 0.01a |
DG | |||
SFA | 39.4 ± 0.89 | 36.0 ± 1.47b | 36.5 ± 0.92 |
MUFA | 38.5 ± 1.70 | 47.5 ± 1.26a | 50.1 ± 1.00c |
DUFA | 12.0 ± 0.64 | 10.1 ± 0.86 | 9.10 ± 0.48a |
PUFA | 10.0 ± 0.84 | 6.38 ± 0.66b | 4.36 ± 0.17c,d |
CE | |||
SFA | 35.2 ± 0.69 | 32.8 ± 0.83 | 29.7 ± 0.60c,d |
MUFA | 25.1 ± 0.91 | 22.7 ± 0.92 | 21.8 ± 0.80b |
DUFA | 32.3 ± 1.08 | 35.9 ± 1.06 | 38.9 ± 1.11a |
PUFA | 7.32 ± 0.49 | 8.61 ± 0.56 | 9.59 ± 0.36a |
Cardiolipin | |||
SFA | 0.26 ± 0.05 | 0.38 ± 0.16 | 0.41 ± 0.08 |
MUFA | 11.5 ± 0.44 | 12.8 ± 1.55 | 12.8 ± 0.36b |
DUFA | 87.4 ± 0.47 | 86.0 ± 1.70 | 86.0 ± 0.38b |
PUFA | 0.83 ± 0.08 | 0.76 ± 0.07 | 0.81 ± 0.06 |
Acylcarnitine | |||
SFA | 62.7 ± 3.65 | 52.3 ± 4.69 | 57.9 ± 2.63 |
MUFA | 25.0 ± 3.68 | 32.0 ± 3.97 | 36.0 ± 2.45b |
DUFA | 12.3 ± 2.58 | 15.7 ± 4.85 | 6.19 ± 0.88 |
PUFA | — | — | — |
Data in each lipid class are shown as mean ± SEM and were analyzed with the Kruskal-Wallis test and corrected for multiple comparisons with the Benjamini-Hochberg approach. The Mann-Whitney U test corrected with the Dunn-Sidak approach was the post hoc analysis (n = 16 for CTRL; n = 10 for NAFL; n = 32 for NASH).
P < 0.01 versus CTRL.
P < 0.05 versus CTRL.
P < 0.001 versus CTRL.
P < 0.05 versus NAFL.